Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials

Autor: Chaturvedi, Nish, Porta, Massimo, Klein, Ronald, Orchard, Trevor, Fuller, John, Parving, Hans Henrik, Bilous, Rudy, Sjølie, Anne Katrin
Zdroj: In The Lancet 2008 372(9647):1394-1402
Databáze: ScienceDirect